Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists; and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat other non-exclusive diseases and conditions; and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems, and InPen, a smart insulin pen system. The company was founded in 1949 and is headquartered in Galway, Ireland.

Medtronic plc.

Medtronic (MDT) has disclosed a new risk, in the Litigation & Legal Liabilities category. Medtronic faces a broad range of ongoing and potential le...

Medtronic Warns Broad Legal Risks Could Materially Impact Financial Performance

Electrolux AB ( ($SE:ELUX.B) ) has provided an announcement. Electrolux Group’s fully underwritten rights issue with preferential rights for existi...

Electrolux Raises SEK 9.1 Billion in Oversubscribed Rights Issue

Insiders have been trading these 5 stocks: (($TTWO)), (($MDT)), (($WM)), (($RUN)) and (($TSE:HIVE)). Here is a breakdown of their recent trades and...

Insider Shake-Up at Take-Two, Medtronic, Waste Management, Sunrun, HIVE

J.P. Morgan analyst Robbie Marcus maintained a Hold rating on Medtronic yesterday and set a price target of $86.00. The company’s shares closed yes...

J.P. Morgan Reaffirms Their Hold Rating on Medtronic (MDT)

Analysts are intrested in these 5 stocks: ( ($LDOS) ), ( ($BBIO) ), ( ($TE) ), ( ($EC) ) and ( ($MDT) ). Here is a breakdown of their recent


Leidos, BridgeBio, T1 Energy, Ecopetrol, Medtronic Trending

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Viatris (VTRS), Medtronic (MDT) and Vertex Pharmaceuticals (VRTX)...

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Viatris (VTRS), Medtronic (MDT) and Vertex Pharmaceuticals (VRTX)

RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Medtronic yesterday and set a price target of $118.00. The company’s shares clos...

RBC Capital Sticks to Their Buy Rating for Medtronic (MDT)

Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Medtronic today and set a price target of $102.00. Biegelsen covers the Healthcare s...

Wells Fargo Reaffirms Their Buy Rating on Medtronic (MDT)

TD Cowen analyst Josh Jennings reiterated a Buy rating on Medtronic today and set a price target of $119.00. According to TipRanks, Jennings is a 2...

TD Cowen Keeps Their Buy Rating on Medtronic (MDT)

Here’s a look at today’s key earnings reports from major publicly traded companies. Stock market investors will undoubtedly be watching closely for...

These Are the Stocks Reporting Earnings Today – June 3, 2026

Stocks ended the week slightly higher as investors balanced a firmer equity tape with rising bond yields, weaker oil prices, and another busy round...

The Week That Was, The Week Ahead: Macro and Markets, May 31

Electrolux AB ( ($SE:ELUX.B) ) has issued an announcement. Electrolux AB shareholders approved amendments to the company’s Articles of Association ...

Electrolux Wins Shareholder Backing for Capital Structure Changes and Rights Issue

Analysts are intrested in these 5 stocks: ( ($OXY) ), ( ($GTM) ), ( ($GEHC) ), ( ($IRD) ) and ( ($MDT) ). Here is a breakdown of their recent


Occidental, ZoomInfo, GEHC, Opus, Medtronic Trending by Analysts

Electrolux AB ( ($SE:ELUX.B) ) just unveiled an update. Electrolux Group has set the terms for a fully underwritten SEK 9.06 billion rights issue, ...

Electrolux launches fully underwritten SEK 9 billion rights issue to fund growth and strengthen balance sheet

In a report released today, David Roman from Goldman Sachs initiated coverage with a Hold rating on Medtronic and a price target of $84.00. Roman c...

Medtronic (MDT) Initiated with a Hold at Goldman Sachs

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Medtronic (MDT) and Vyome Holdings (HIND) with bulli...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	MDT	$79.34	+1.54%	22.66M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	MDT	$79.34	+1.5%	22.66M
3
4
5
6

MDT

MDT

Get Medtronic plc. Data in Excel

Get Medtronic plc. Data in Excel